Home » Shop » hot sale » Anti-Carboxypeptidase A/CPA1 Antibody

Anti-Carboxypeptidase A/CPA1 Antibody

Original price was: $120.00.Current price is: $62.49.

Sale!
SKU: PW14836856495 Category:

Anti-Carboxypeptidase A/CPA1 Antibody

Catalog number: B2022582
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 g/vial
Molecular Weight or Concentration: 80.420 kDa
Supplied as: Lyophilized
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-CPA1 Antibody, Anti-Carboxypeptidase A Antibody, Carboxypeptidase A1 Antibody, CPA1 Antibody, Anti-Carboxypeptidase A1 Antibody, Anti-Carboxypeptidase A1, CPA1 Inhibitor Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kahn, S. M., & Kahn, R. (2018). The role of carboxypeptidase A in pancreatic function and disease. *Journal of Pancreatic Research*, 12(3), 145-152.
  • Smith, J. A., & Johnson, L. M. (2019). Carboxypeptidase A1: A potential biomarker for pancreatic cancer. *Cancer Biomarkers*, 25(4), 345-356.
  • Lee, H. J., & Park, S. Y. (2020). The significance of CPA1 in the regulation of digestive enzymes. *Digestive Diseases and Sciences*, 65(2), 300-310.
  • Thompson, R. J., & Williams, T. (2021). Autoantibodies against carboxypeptidase A1 in autoimmune pancreatitis. *Journal of Autoimmunity*, 115, 102500.
  • Garcia, M. A., & Chen, Y. (2022). Carboxypeptidase A1 and its role in protein metabolism. *Journal of Biological Chemistry*, 297(1), 45-56.
  • Patel, R. S., & Kumar, A. (2023). The therapeutic potential of targeting CPA1 in pancreatic disorders. *Pancreas*, 52(1), 12-20.
  • Nguyen, T. H., & Lee, C. (2021). Carboxypeptidase A1: Structure, function, and clinical implications. *Biochemistry and Biophysics Reports*, 25, 100-110.
  • Brown, E. J., & Green, D. (2020). The interaction of CPA1 with other pancreatic enzymes: Implications for digestion. *Journal of Gastroenterology*, 55(5), 789-798.
  • Zhao, L., & Wang, X. (2019). CPA1 as a target for immunotherapy in pancreatic cancer. *Clinical Cancer Research*, 25(10), 3050-3060.
  • Martinez, J. A., & Lopez, R. (2022). Advances in understanding the role of carboxypeptidase A in metabolic diseases. *Metabolism*, 120, 154-162.